Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.

Translated title of the contribution: Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.
Original language	Undefined/Unknown
Pages (from-to)	43-52
Number of pages	10
Journal	BioDrugs
Volume	26
Issue number	1
DOIs	https://doi.org/10.2165/11599490-000000000-00000.
Publication status	Published - 2012

Access to Document

@article{f049f47907e544928bcdb63638420cbe,

title = "Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.",

author = "A. Relan and K. Bakhtiari and \{van Amersfoort\}, E.S. and J.C. Meijers and C.E. Hack",

year = "2012",

doi = "10.2165/11599490-000000000-00000.",

language = "Undefined/Unknown",

volume = "26",

pages = "43--52",

journal = "BioDrugs",

issn = "1173-8804",

publisher = "Adis",

number = "1",

}

TY - JOUR

T1 - Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.

AU - Relan, A.

AU - Bakhtiari, K.

AU - van Amersfoort, E.S.

AU - Meijers, J.C.

AU - Hack, C.E.

PY - 2012

Y1 - 2012

U2 - 10.2165/11599490-000000000-00000.

DO - 10.2165/11599490-000000000-00000.

M3 - Article

SN - 1173-8804

VL - 26

SP - 43

EP - 52

JO - BioDrugs

JF - BioDrugs

IS - 1

ER -